In today’s highly competitive Life Sciences industry, companies know they must work together to bring innovative products and services to market in a timely and effective manner.
As market and financial pressures mount, companies are increasingly seeking ways to accelerate timelines, expand capacity and cut costs. By leveraging the expertise and capabilities of partners, companies can make investments and development decisions more quickly and efficiently.
For 20 years, SDIX has delivered unique diagnostic, research and discovery solutions for its partners through the creation, development and commercialization of assays, antibodies and critical reagents. In fact, SDIX’s custom, applications-driven solutions have demonstrated success in advancing the R&D and commercialization goals of its partners - in industry (from human health to industrial diagnostic to biopharmaceutical) and in academia.
SDIX core competencies and proprietary technologies are being used to facilitate the discovery and understanding of the mechanisms of disease, to contribute to the creation and development of new drugs, and to deliver systems for rapid diagnosis of a diverse set of biomolecules.
Over the course of its history, SDIX has engaged in a variety of partnerships, including:
- All of the top IVD companies
- 14 of the top 20 Pharmaceutical and Biotech companies
- 3 of the top 5 antibody reagent suppliers
- Most of the major food producers, processors, and marketers
SDIX recognizes that many technologies that could impact its goals of empowering research may be discoveries that occur outside its laboratories. As a result, SDIX maintains an eye on the future, always seeking the latest technologies and breakthrough science to deliver state-of-the-art and challenging biomolecules to our partners.
To explore how SDIX can work together with you to develop or commercialize technology or help you meet your R&D and product development goals, contact:
VP and General Counsel